• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水飞蓟宾通过下调 COX-2 抑制 TPA 诱导的人乳腺癌细胞 MMP-9 表达。

Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.

机构信息

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-gu, Seoul 135-710, South Korea.

出版信息

J Ethnopharmacol. 2009 Nov 12;126(2):252-7. doi: 10.1016/j.jep.2009.08.032. Epub 2009 Aug 26.

DOI:10.1016/j.jep.2009.08.032
PMID:19715751
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

The expression of matrix metalloproteinase-9 (MMP-9) and cyclooxygenase-2 (COX-2) are pivotal steps in breast cancer pathogenesis. In a previous study, we reported that silibinin suppresses TPA-induced MMP-9 expression through the Raf/MEK/ERK pathway.

AIMS OF THE STUDY

Herein we determined the co-relationship between MMP-9 and COX-2, as well as the effect of silibinin on 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced MMP-9 and COX-2 expression in the human breast cancer cells, MCF-7 and MDA-MB231.

METHODS

The toxicity of silibinin was evaluated by Quick Cell Proliferation Assay Kit II. MMP-9 and COX-2 expression were analyzed by Zymography and Western blotting, respectively. Adenoviral constitutively active (CA)-MEK was used to activate MEK/ERK pathway.

RESULTS

The expression of MMP-9 and COX-2 in response to TPA was increased, whereas TPA-induced MMP-9 and COX-2 expression was decreased by silibinin. Our results showed that TPA-induced MMP-9 expression was inhibited by celecoxib in a dose-dependent fashion, but not MMP-1-expression. Both MMP-9 and COX-2 expression were significantly increased by CA-MEK overexpression. In contrast, TPA-induced MMP-9 and COX-2 expression was decreased by UO126 (MEK 1/2 inhibitor).

CONCLUSION

Silibinin down-regulates TPA-induced MMP-9 expression through inhibition of COX-2 expression in breast cancer cells.

摘要

民族药理学相关性

基质金属蛋白酶-9(MMP-9)和环氧化酶-2(COX-2)的表达是乳腺癌发病机制中的关键步骤。在之前的研究中,我们报道了水飞蓟宾通过 Raf/MEK/ERK 通路抑制 TPA 诱导的 MMP-9 表达。

研究目的

本文旨在确定 MMP-9 和 COX-2 之间的相关性,以及水飞蓟宾对 TPA 诱导的 MMP-9 和 COX-2 在人乳腺癌细胞 MCF-7 和 MDA-MB231 中的表达的影响。

方法

通过快速细胞增殖试剂盒 II 评估水飞蓟宾的毒性。通过明胶酶谱法和 Western blot 分别分析 MMP-9 和 COX-2 的表达。使用腺病毒组成型激活(CA)-MEK 激活 MEK/ERK 通路。

结果

TPA 诱导 MMP-9 和 COX-2 的表达增加,而水飞蓟宾则降低了 TPA 诱导的 MMP-9 和 COX-2 的表达。我们的结果表明,TPA 诱导的 MMP-9 表达被塞来昔布呈剂量依赖性抑制,但不抑制 MMP-1 的表达。CA-MEK 的过表达显著增加了 MMP-9 和 COX-2 的表达。相反,UO126(MEK1/2 抑制剂)降低了 TPA 诱导的 MMP-9 和 COX-2 的表达。

结论

水飞蓟宾通过抑制乳腺癌细胞中 COX-2 的表达下调 TPA 诱导的 MMP-9 表达。

相似文献

1
Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.水飞蓟宾通过下调 COX-2 抑制 TPA 诱导的人乳腺癌细胞 MMP-9 表达。
J Ethnopharmacol. 2009 Nov 12;126(2):252-7. doi: 10.1016/j.jep.2009.08.032. Epub 2009 Aug 26.
2
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.水飞蓟宾通过使MCF-7人乳腺癌细胞中的Raf/MEK/ERK信号通路失活,来阻止佛波酯(TPA)诱导的基质金属蛋白酶-9(MMP-9)表达和血管内皮生长因子(VEGF)分泌。
Phytomedicine. 2009 Jun;16(6-7):573-80. doi: 10.1016/j.phymed.2008.11.006. Epub 2009 Jan 31.
3
12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells.水飞蓟宾通过下调 cyclin B1 和 cdc2 的表达以及上调 p21 的表达,增强 12-O-十四烷酰佛波醇-13-乙酸酯(TPA)诱导的 MDA-MB231 人乳腺癌细胞生长阻滞。
Phytomedicine. 2010 Dec 1;17(14):1127-32. doi: 10.1016/j.phymed.2010.03.013.
4
Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.水飞蓟宾抑制 TPA 诱导的甲状腺和乳腺癌细胞迁移和 MMP-9 表达。
Oncol Rep. 2013 Apr;29(4):1343-8. doi: 10.3892/or.2013.2252. Epub 2013 Jan 24.
5
Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.芳基-姜黄烯通过抑制 TPA 诱导的乳腺癌细胞中 NF-κB 的激活来减弱 MMP-9 和 COX-2 的侵袭和表达。
J Cell Biochem. 2012 Dec;113(12):3653-62. doi: 10.1002/jcb.24238.
6
Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.水飞蓟宾通过阻断丝裂原活化蛋白激酶(MAPK)信号通路介导的活化蛋白-1(AP-1)激活,抑制佛波酯(PMA)诱导的MCF-7人乳腺癌细胞基质金属蛋白酶-9(MMP-9)的表达。
Biochem Biophys Res Commun. 2007 Mar 2;354(1):165-71. doi: 10.1016/j.bbrc.2006.12.181. Epub 2007 Jan 2.
7
TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.TPA 诱导的 p21 表达通过一种不依赖 p53 的机制增强人乳腺癌细胞的 G2/M 期阻滞。
Oncol Rep. 2012 Feb;27(2):517-22. doi: 10.3892/or.2011.1511. Epub 2011 Oct 20.
8
Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-kappaB as a potential molecular target.毛钩藤酮抑制佛波酯诱导的人乳腺上皮细胞中COX-2和MMP-9的上调:NF-κB作为潜在分子靶点
FEBS Lett. 2006 Jan 23;580(2):385-92. doi: 10.1016/j.febslet.2005.12.015. Epub 2005 Dec 19.
9
Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.刺楸皂苷A通过PI3K/Akt和PKCδ介导的信号通路降低基质金属蛋白酶-9,从而抑制佛波酯诱导的MCF-7人乳腺癌细胞侵袭。
Carcinogenesis. 2009 Jul;30(7):1225-33. doi: 10.1093/carcin/bgp111. Epub 2009 May 6.
10
Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells.细胞外信号调节激酶(ERK)和p38丝裂原活化蛋白激酶在佛波酯诱导人乳腺上皮细胞中核因子κB激活及环氧化酶-2表达中的作用
Chem Biol Interact. 2008 Jan 30;171(2):133-41. doi: 10.1016/j.cbi.2007.07.008. Epub 2007 Jul 26.

引用本文的文献

1
Mechanistic Insights into Silymarin-Induced Apoptosis and Growth Inhibition in SPC212 Human Mesothelioma Cells.水飞蓟素诱导SPC212人恶性间皮瘤细胞凋亡和生长抑制的机制研究
Cell Biochem Biophys. 2025 Jun;83(2):2405-2414. doi: 10.1007/s12013-024-01650-w. Epub 2025 Jan 2.
2
Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer.天然产物作为基质金属蛋白酶调节剂用于癌症治疗
Biomedicines. 2024 Apr 3;12(4):794. doi: 10.3390/biomedicines12040794.
3
Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.
探讨膳食植物化学物对乳腺癌患者的抗癌潜力:全面综述。
Cancer Med. 2023 Jul;12(13):14556-14583. doi: 10.1002/cam4.5984. Epub 2023 May 3.
4
MMP9: A Tough Target for Targeted Therapy for Cancer.基质金属蛋白酶9:癌症靶向治疗的一个棘手靶点。
Cancers (Basel). 2022 Apr 6;14(7):1847. doi: 10.3390/cancers14071847.
5
Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.靶向癌症特征:水飞蓟宾对结直肠癌细胞增殖、细胞死亡、血管生成和迁移的影响。
BMC Complement Med Ther. 2021 May 31;21(1):160. doi: 10.1186/s12906-021-03330-1.
6
Korean Red Ginseng suppresses bisphenol A-induced expression of cyclooxygenase-2 and cellular migration of A549 human lung cancer cell through inhibition of reactive oxygen species.韩国红参通过抑制活性氧抑制双酚A诱导的A549人肺癌细胞环氧化酶-2表达和细胞迁移。
J Ginseng Res. 2021 Jan;45(1):119-125. doi: 10.1016/j.jgr.2020.01.002. Epub 2020 Jan 14.
7
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells.水飞蓟宾诱导人肝癌细胞发生细胞凋亡的同时伴随着神经酰胺合成和 miRNA 分泌的增加。
Int J Mol Sci. 2019 May 3;20(9):2190. doi: 10.3390/ijms20092190.
8
Celecoxib in breast cancer prevention and therapy.塞来昔布在乳腺癌预防与治疗中的应用
Cancer Manag Res. 2018 Oct 26;10:4653-4667. doi: 10.2147/CMAR.S178567. eCollection 2018.
9
Natural Products for the Management and Prevention of Breast Cancer.用于乳腺癌管理与预防的天然产物
Evid Based Complement Alternat Med. 2018 Feb 26;2018:8324696. doi: 10.1155/2018/8324696. eCollection 2018.
10
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.瑞戈非尼联合水飞蓟宾作为治疗转移性结直肠癌的一种新型潜在策略。
Oncotarget. 2017 Aug 7;8(40):68305-68316. doi: 10.18632/oncotarget.20054. eCollection 2017 Sep 15.